Search>Brands>Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

Drug Manufacturers - General·Princeton, NY, US·NYSE: BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in ri…

HEADQUARTERSPrinceton, NY

CEOChristopher S. Boerner

SECTORHealthcare

EMPLOYEES34,100

IPO DATE1972

WEBSITEwww.bms.com

All Marks

Showing 1–25 of 291 marks

REVLIMIDSerial No. 78290583 · IC 005

Filed 2003-08-21RegisteredView

PATIENT SUPPORT SOLUTIONSSerial No. 78635668 · IC 035

Filed 2005-05-24RegisteredView

CELGENE CELLULAR THERAPEUTICSSerial No. 78738956 · IC 042

Filed 2005-10-24RegisteredView

REVSerial No. 78402492 · IC 005

Filed 2004-04-15RegisteredView

PSCSerial No. 77012219 · IC 035

Filed 2006-10-03RegisteredView

REVLIMIDSerial No. 78795942 · IC 005

Filed 2006-01-20RegisteredView

IMIDSSerial No. 76570112 · IC 040

Filed 2004-01-14RegisteredView

IMIDSSerial No. 78881247 · IC 005

Filed 2006-05-11RegisteredView

COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDESerial No. 77036385 · IC 042

Filed 2006-11-03RegisteredView

ATTENADESerial No. 77077497 · IC 005

Filed 2007-01-06RegisteredView

CELGENESerial No. 77244039 · IC 035

Filed 2007-08-01RegisteredView

IMIDSerial No. 77012432 · IC 005

Filed 2006-10-03RegisteredView

REVDEXSerial No. 77475256 · IC 005

Filed 2008-05-15RegisteredView

IMPROVING THE LIVES OF PATIENTS WORLDWIDESerial No. 77672700 · IC 042

Filed 2009-02-18RegisteredView

CELGENE COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDESerial No. 77561055 · IC 042

Filed 2008-09-03RegisteredView

CELGENE PATIENT SUPPORTSerial No. 77739125 · IC 035

Filed 2009-05-18RegisteredView

CONNECTSerial No. 77672617 · IC 035

Filed 2009-02-18RegisteredView

CITRESerial No. 77919417 · IC 042

Filed 2010-01-25RegisteredView

CELGENE INSTITUTE FOR TRANSLATIONAL RESEARCH EUROPESerial No. 77919187 · IC 042

Filed 2010-01-25RegisteredView

ONE SOURCE, MANY POSSIBILITIESSerial No. 77907651 · IC 035

Filed 2010-01-08RegisteredView

CONNECT CLLSerial No. 85026205 · IC 035

Filed 2010-04-29RegisteredView

POMALYSTSerial No. 85150878 · IC 005

Filed 2010-10-12RegisteredView

POMALYST REMSSerial No. 85893911 · IC 044

Filed 2013-04-03RegisteredView

THALOMID REMSSerial No. 85893863 · IC 044

Filed 2013-04-03RegisteredView

ARTIMIDSSerial No. 86339895 · IC 044

Filed 2014-07-17RegisteredView

Page 1 of 12

Bristol-Myers Squibb Company

Trademark Overview

Filing Activity

All Marks